S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia–reperfusion injury and fibrosis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110110 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jing Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Acute Kidney Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Renal ischemia/reperfusion injury (IRI) is a significant clinical problem without effective therapy. Unbiased omics approaches may reveal key renal mediators to initiate IRI. S100-A8/A9 was identified as the most significantly upregulated gene and protein base on proteomic analysis and RNA sequencing during the early reperfusion stage. S100-A8/A9 levels were significantly increased 1 day after transplantation in patients with donation after brain death (DBD). S100-A8/A9 production was associated with CD11b+Ly6G+ CXCR2+ immunocytes infiltration. Administration of S100-A8/A9 blocker ABR238901 significantly alleviates renal tubular injury, inflammatory cell infiltration, and renal fibrosis after renal IRI. Mechanistically, S100-A8/A9 could promote renal tubular cell injury and profibrotic cytokine production via TLR4. In conclusion, our findings found that early activation of S100-A8/A9 in renal IRI and targeting S100-A8/A9 signaling alleviates tubular injury and inhibits inflammatory response and renal fibrosis, which may provide a novel target for the prevention and treatment of acute kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Nephrology, The First Clinical Medical College of Three Gorges University, Center People's Hospital of Yichang, Yichang, Hubei 443000, China.
- Department of Organ transplantation, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Electronic address: rm003155@whu.edu.cn.
- Department of Nephrology, The First Clinical Medical College of Three Gorges University, Center People's Hospital of Yichang, Yichang, Hubei 443000, China. Electronic address: songzhixia@ctgu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, J., Shi, L., Xia, Y., Zhu, J., Zha, H., Wu, X., & Song, Z. (2023). S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia–reperfusion injury and fibrosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110110
Vancouver
Huang J, Shi L, Xia Y, Zhu J, Zha H, Wu X, et al. S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia–reperfusion injury and fibrosis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110110
BibTeX
@article{Huang2023,
author = {Huang, Jing and Shi, Lang and Xia, Yao and Zhu, Jiefu and Zha, Hongchu and Wu, Xiongfei and Song, Zhixia},
title = {S100-A8/A9 activated TLR4 in renal tubular cells to promote ischemia–reperfusion injury and fibrosis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110110}
}
EUVIMED